• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
BCTX

BCTX

BriaCell Therapeutics Corp.

NASDAQHealthcareBiotechnologyCA

USD3.31

+0.04 (+1.22%)

Rating:C+

Company Profile

CEO

William V. Williams

IPO Date

2012-03-14

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

CA

Market Metrics

Open

$3.28

Prev. Close

$3.27

Day Low

$3.18

Day High

$3.42

52W Low

$2.98

52W High

$36.00

Market Cap

$0.01B

Volume

0.14M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

40.5%

Avg Negative

3.0%

Avg Neutral

56.8%

News Feed

BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial

Benzinga·8/19/2021·↑ positive

BriaCell Therapeutics Attacks Cancer with Novel Off-the-Shelf Immunotherapies

Benzinga·8/16/2021·↓ negative

BriaCell's Early-Stage Combination Study In Advanced Breast Cancer Starts Enrollment

Benzinga·7/14/2021·↑ positive

BCTX Stock Price Increased 8.96%: Why It Happened

Pulse2·6/17/2021·↑ positive

Why Shares Of BriaCell Therapeutics Surged Today

Benzinga·6/16/2021·↑ positive

BriaCell Extends Personalized Breast Cancer Immunotherapy To Prostate & Lung Cancer And Melanoma

Benzinga·6/16/2021·↑ positive

BriaCell Therapeutics Corp. Announces Closing of US$27.2 Million Private Placement

GlobeNewsWire·6/7/2021·↓ negative

BriaCell Reports 12.0 Months Overall Survival Benefit in Advanced Breast Cancer; 100% Resolution of ‘Eye-Bulging' Tumor

GlobeNewsWire·6/2/2021·↑ positive

BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting

GlobeNewsWire·5/19/2021·↑ positive

BriaCell Announces Investor and Media Outreach Programs

GlobeNewsWire·4/15/2021·↑ positive